eCite Digital Repository

How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed?


Burgess, John, How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed?, Clinical Endocrinology, 72, (1) pp. 13-16. ISSN 0300-0664 (2010) [Refereed Article]

DOI: doi:10.1111/j.1365-2265.2009.03662.x


Multiple endocrine neoplasia type 1 (MEN 1) is a complex multi-system disease manifesting a diverse range of primary and secondary metabolic and neoplastic disorders. It is possible to improve patient prognosis by early disease detection and treatment. Regular biochemical and radiological screening for parathyroid, gastro-enteropancreatic, pituitary, intrathorasic and adrenal lesions forms the basis of surveillance. The likelihood of adverse sequelea such as renal and bone disease resulting from hyperparathyroidism, severe peptic ulceration and gastric carcinoidosis secondary to hypergastrinaemia can be ameliorated by early detection and management

Item Details

Item Type:Refereed Article
Research Division:Biomedical and Clinical Sciences
Research Group:Clinical sciences
Research Field:Endocrinology
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Burgess, John (Professor John Burgess)
ID Code:96141
Year Published:2010
Web of Science® Times Cited:15
Deposited By:Medicine
Deposited On:2014-10-21
Last Modified:2014-10-21

Repository Staff Only: item control page